G protein-coupled receptors: novel targets for drug discovery in cancer

By Rosamaria Lappano, Marcello Maggiolini. Nature reviews. Drug discovery, 2010

728 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/1e2eb53d4410f19ba8694f7fd0152627a431f4ec

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Fa-Xing Yu
2. K. Guan
3. David M. Sabatini
4. Michael N. Hall
5. M. Laplante
6. D. Hardie
7. Asier González González
8. R. Shaw

In Oncology

1. K. Guan
2. Fa-Xing Yu

Citations in the corpus

• The Hippo pathway: regulators and regulations. (2013, background): “GPCR represents the largest family of plasma membrane receptors that can be activated or inactivated by a wide range of physiological ligands or pharmaceutical drugs (Lappano and Maggiolini 2011).”
• Mechanisms of Hippo pathway regulation (2016, neutral): “…increased expansion of progenitor cells, and tissue overgrowth (Camargo et al. 2007; Dong et al. 2007; Zhou et al. 2009; Cai et al. 2010; Lee et al. 2010; Lu et al. 2010; Song et al. 2010; Zhang et al. 2010; Nishio et al. 2012; Chen et al. 2015b), supporting the functional roles of…”